Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar 10;59(3):2102806.
doi: 10.1183/13993003.02806-2021. Print 2022 Mar.

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination

Affiliations
Comment

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination

Tomohiro Bando et al. Eur Respir J. .

Abstract

Although the association between acute exacerbation of interstitial lung disease and vaccination is not yet clarified, this is the first case report describing the possibility that SARS-CoV-2 vaccination may trigger acute exacerbation https://bit.ly/3tpu6Cz

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: T. Bando, R. Takei, Y. Mutoh, H. Sasano, Y. Yamano, T. Yokoyama, T. Matsuda, K. Kataoka and T. Kimura have nothing to disclose. Y. Kondoh reports funding from Nippon Boehringer Ingelheim Co. Ltd, consulting fees from Asahi Kasei Pharma Corp., Shionogi & Co. Ltd, Boehringer Ingelheim Co. Ltd, Janssen Pharmaceutical K.K., Healios K.K. and Taiho Pharmaceutical Co. Ltd, and payment for lectures from Asahi Kasei Pharma Corp., Shionogi & Co. Ltd, Boehringer Ingelheim Co. Ltd, Actelion Pharmaceuticals Ltd, DAIICHI SANKYO Co. Ltd, Bristol Myers Squibb, AstraZeneca K.K., Eisai inc., KYORIN Pharmaceutical Co. Ltd, Mitsubishi Tanabe Pharma and Novartis Pharma K.K., outside the submitted work.

Figures

FIGURE 1
FIGURE 1
High-resolution computed tomography (HRCT) and chest radiograph findings with simple clinical course. a) 8 months prior to admission, subpleural reticulation and honeycomb structure are present, compatible with fibrotic interstitial lung disease. b) Chest images on admission. Newly developed bilateral and diffuse ground-glass opacities (GGO) and underlying subpleural honeycomb and reticulation are seen on HRCT. c) Chest images before discharge. GGO has improved. Below, the clinical course is shown. Numbers show clinical days from second vaccination. BAL: bronchoalveolar lavage; mPSL: methylprednisolone.

Comment on

References

    1. Polack FP, Thomas SJ, Kitchin N, et al. . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603–2615. doi:10.1056/NEJMoa2034577 - DOI - PMC - PubMed
    1. El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. . Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med 2021; 14: 1389–1401. doi:10.2147/IJGM.S310497 - DOI - PMC - PubMed
    1. Drake TM, Docherty AB, Harrison EM, et al. . Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. Am J Respir Crit Care Med 2020; 202: 1656–1665. doi:10.1164/rccm.202007-2794OC - DOI - PMC - PubMed
    1. Kondoh Y, Kataoka K, Ando M, et al. . COVID-19 and acute exacerbation of interstitial lung disease. Respir Investig 2021; 59: 675–678. doi:10.1016/j.resinv.2021.06.007 - DOI - PMC - PubMed
    1. Collard HR, Ryerson CJ, Corte TJ, et al. . Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med 2016; 194: 265–275. doi:10.1164/rccm.201604-0801CI - DOI - PubMed

Substances